CN113699103A - Induced reinforcement preparation process and application of poultry mesenchymal stem cell exosomes - Google Patents

Induced reinforcement preparation process and application of poultry mesenchymal stem cell exosomes Download PDF

Info

Publication number
CN113699103A
CN113699103A CN202110794777.XA CN202110794777A CN113699103A CN 113699103 A CN113699103 A CN 113699103A CN 202110794777 A CN202110794777 A CN 202110794777A CN 113699103 A CN113699103 A CN 113699103A
Authority
CN
China
Prior art keywords
mesenchymal stem
curcumin
exosome
poultry
exosomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110794777.XA
Other languages
Chinese (zh)
Other versions
CN113699103B (en
Inventor
谢儒生
金玉堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shengyi Biotechnology Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110794777.XA priority Critical patent/CN113699103B/en
Publication of CN113699103A publication Critical patent/CN113699103A/en
Application granted granted Critical
Publication of CN113699103B publication Critical patent/CN113699103B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0668Mesenchymal stem cells from other natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a process for preparing an induced aid of an avian mesenchymal stem cell exosome, which comprises the following steps: performing primary separation culture on the poultry mesenchymal stem cells, performing subculture, taking the poultry mesenchymal stem cells, culturing by using a cell growth medium, discarding the culture medium, washing the cells for three times by using a phosphate buffer solution, adding curcumin for stimulation, continuously culturing for 72 hours by using a serum-free culture medium, collecting the serum-free culture medium, and continuously performing the treatment on the cells which are not collected until a sufficient amount of supernatant is collected; centrifuging the collected curcumin-stimulated serum-free culture solution, extracting and concentrating the exosome filtrate, and sterilizing the obtained exosome concentrated filtrate. The invention stimulates and induces poultry mesenchymal stem cells by curcumin through improving the process formula, promotes the production of exosomes boosted by curcumin, and has more excellent effect compared with exosomes without the boosting effect of curcumin.

Description

Induced reinforcement preparation process and application of poultry mesenchymal stem cell exosomes
Technical Field
The invention relates to a preparation method of stem cell exosomes, in particular to a preparation process and application of induced aid of avian mesenchymal stem cell exosomes, and belongs to the technical field of stem cell biomedicines.
Background
The source of the poultry mesenchymal stem cells is wide, the materials are easy to obtain, the cell separation efficiency is high, the cell strain state is stable, and the medical ethical problem does not exist, so that the poultry mesenchymal stem cells are gradually paid attention to. Exosomes are nanoscale vesicles that are released outside of a cell upon environmental stimulation or activation of the cell. Vesicle structures are classified into 3 types according to their diameter: exosomes (diameter 40-150 nm), microvesicles (diameter 100-1000 nm) and apoptotic bodies (diameter 1-4 μm). The exosome is formed by gathering substances such as protein, DNA (deoxyribonucleic acid) fragments, miRNA (micro ribonucleic acid) and the like in cytoplasm into a multi-vesicle endosome through an endocytosis path, and then fusing and cracking the multi-vesicle and a plasma membrane to release the multi-vesicle endosome to the outside of cells to form the exosome. The internal structure of exosomes mainly depends on the cell from which they are derived, but most exosomes are rich in integrins, heat shock proteins, the tetraspanin superfamily (CD9, CD63, CD81 and CD82), the cell endogenous proteins alix and the Rab protein family, and these proteins can be used as reliable markers for identifying exosomes.
Exosomes have functions of helping to remove old and useless cells and substituting with new cells, and are regarded as important substances effective in combating the aging and repair of skin. In addition to the development of applications at the beauty end, it was also found that exosomes also have an improving effect on allergic rhinitis caused by air pollution or seasonal alternation. If the exosome is prepared into an inhalation spray type, and is inhaled through the nasal cavity and the oral cavity, the exosome can pass through the nasal mucosa, the inflammatory reaction at the nasal mucosa is relieved, and the symptoms of nasal obstruction, rhinorrhea, asthma and the like are improved.
At present, although studies have been made on the use of specific induction conditions for inducing stem cells to secrete supernatants in vitro for medical treatment, cosmetics and the like, these conditioned media achieve therapeutic effects by inducing stem cells to secrete certain specific factors using specific cytokines, and the cytokines themselves are expensive, which results in an abnormally high cost of application of stem cells.
Disclosure of Invention
The technical problem to be solved by the invention is to overcome the defects of the prior art and provide an induced reinforcement preparation process and application of the poultry mesenchymal stem cell exosomes, wherein curcumin is used for stimulating and inducing poultry mesenchymal stem cells to promote the production of exosomes reinforced by curcumin, and the effect of the exosomes is more excellent than that of exosomes not reinforced by curcumin.
In order to solve the technical problems, the invention provides a process for preparing an induced aid of an avian mesenchymal stem cell exosome, which comprises the following steps:
s1: carrying out primary isolation culture on the poultry mesenchymal stem cells, carrying out subculture, and taking subcultured P3-P30 generation human adipose mesenchymal stem cells;
s2: culturing with cell growth liquid until 75-85% of cells are fused, discarding the culture liquid, washing the cells with phosphate buffer solution for three times, adding curcumin, culturing with serum-free culture liquid for 72 hr, and collecting the serum-free culture liquid;
s3: continuing the curcumin stimulation treatment of the step until the serum-free culture solution is collected, wherein the cells which are not collected in the step S2 are not collected;
s4: collecting serum-free culture solution stimulated by curcumin in the steps S2 and S3, centrifuging, extracting and concentrating the exosome filtrate, and finally preparing the needed curcumin to induce the reinforcement poultry mesenchymal stem cell exosomes after degerming treatment is carried out on the obtained exosome concentrated filtrate;
s5: adding excipient and water into curcumin-induced aid-increasing poultry mesenchymal stem cell exosome, mixing, filtering for sterilization, and freeze-drying to obtain the stem cell extract freeze-dried powder.
Although the curcumin-induced reinforcement poultry mesenchymal stem cell exosome has various biological activities and is wide in application field, the biological activities of the curcumin-induced reinforcement poultry mesenchymal stem cell exosome are limited by various external conditions and are inconvenient to store, so that the invention also provides the cryolite powder of the curcumin-induced reinforcement poultry mesenchymal stem cell exosome, and the cryolite powder is prepared by the cryolite powder preparation method commonly used in the field; the frozen crystal powder is prepared by freezing liquid medicine into solid state in aseptic environment, and then carrying out vacuum pumping to sublimate and dry water.
In a further limited technical scheme of the present invention, in the induced rescue preparation process of the poultry mesenchymal stem cell exosome, the cell growth solution is a DMEM culture solution containing 5% fetal bovine serum, and the culture solution further contains an antibacterial antibiotic; the antibacterial antibiotic is penicillin and streptomycin, wherein the final concentration of penicillin in a cell growth solution is 200U/ml, the final concentration of streptomycin in the cell growth solution is 250U/ml, the DMEM culture solution containing 5% fetal calf serum is obtained by adding 5% of fetal calf serum into a commercially available basic DMEM culture solution, and the penicillin with the final concentration of 200U/ml and the streptomycin with the final concentration of 250U/ml are added to obtain the cell growth solution.
In the induced reinforcement preparation process of the poultry mesenchymal stem cell exosomes, the phosphate buffer solution is a PBS solution with a pH value of 7.0-7.2; the excipient is any one of mannitol, trehalose or sucrose; the dosage of the excipient accounts for 5-10% of the total weight of the curcumin-induced reinforcement poultry mesenchymal stem cell exosomes.
In the induced reinforcement preparation process of the poultry mesenchymal stem cell exosomes, the water in the step S5 is ultrapure water, and the ultrapure water is added to a final volume of 100 ml; the freeze-drying treatment is that the freeze-drying temperature is-20 to-35 ℃, the vacuum degree is 50 to 200Pa, and the freeze-drying is carried out for 48 hours.
Further, in the aforementioned induced aid preparation process of the poultry mesenchymal stem cell exosomes, the centrifugation in step S4 is performed for 1,000xg10 minutes and 10,000xg10 minutes, after that, the supernatant is collected, the collected supernatant is subjected to tangential flow filtration through a hollow fiber membrane, the collected, filtered and concentrated exosome solution is then passed through an exosome extraction system to extract a high-purity exosome solution, and the sterilization treatment is performed by filtering and sterilizing through a sterile 0.22 μm filter membrane.
An application of fowl mesenchymal stem cell exosome comprises preparing wound healing medicine or cell repairing medicine from stem cell extract cryo-crystal powder; preparing a whitening product or a fine chemical product for resisting skin wrinkles.
The invention has the beneficial effects that: according to the invention, through improvement of a process formula, poultry mesenchymal stem cells are stimulated and induced by curcumin, and exosomes boosted by curcumin are promoted to be generated, so that the effect of the exosomes is more excellent than that of exosomes not boosted by curcumin; meanwhile, exosomes secreted by the isolated cells are collected and extracted by a special technology, and are called curcumin-induced reinforcement poultry mesenchymal stem cell exosomes; the curcumin induces the exosomes of the mesenchymal stem cells of the booster poultry to be frozen and dried to produce frozen crystal powder, thereby ensuring the biological activity and the efficacy. The process verified by the invention is mainly to discuss the effect of curcumin induced enhancement poultry mesenchymal stem cell exosome on skin repair.
Drawings
FIG. 1 is a transmission electron microscope image of the present invention before and after lyophilization.
FIG. 2 shows particle size analysis and particle number according to the present invention.
FIG. 3 shows the purity test of the frozen crystal powder of the present invention.
FIG. 4 shows the protein concentration contained in the frozen powder of the present invention.
FIG. 5 shows the RNA concentration of exosomes contained in the cryogel powder of the present invention.
FIG. 6 shows the cell proliferation effect of the cryo-crystal powder of the present invention on human skin fibroblasts.
FIG. 7 shows the effect of cryo-crystal powder of the present invention on cell proliferation of human hair follicle cells.
FIG. 8 is a graph showing the wound healing effect of the cryo-crystal powder of the present invention on human skin fibroblasts.
Detailed Description
The induced reinforcement preparation process of the poultry mesenchymal stem cell exosome provided by the embodiment comprises the following steps:
s1: carrying out primary isolation culture on the poultry mesenchymal stem cells, carrying out subculture, and taking subcultured P3-P30 generation human adipose mesenchymal stem cells;
s2: culturing with cell growth liquid until 75-85% of cells are fused, discarding the culture liquid, washing the cells with phosphate buffer solution for three times, adding curcumin, culturing with serum-free culture liquid for 72 hr, and collecting the serum-free culture liquid;
s3: continuing the curcumin stimulation treatment of the step until the serum-free culture solution is collected, wherein the cells which are not collected in the step S2 are not collected;
s4: collecting serum-free culture solution stimulated by curcumin in the steps S2 and S3, centrifuging, extracting and concentrating the exosome filtrate, and finally preparing the needed curcumin to induce the reinforcement poultry mesenchymal stem cell exosomes after degerming treatment is carried out on the obtained exosome concentrated filtrate; the centrifugation operation adopts the centrifugation process of 1,000Xg10 minutes and 10,000Xg10 minutes, the supernatant is collected after the centrifugation is finished, the collected supernatant flows through a hollow fiber membrane to be subjected to tangential flow filtration, the collected, filtered and concentrated exosome solution is then passed through an exosome extraction system to extract high-purity exosome solution, and the sterilization treatment adopts a sterile 0.22 mu m filter membrane to carry out filtration sterilization;
s5: adding excipient and ultrapure water into curcumin-induced aid-increasing poultry mesenchymal stem cell exosomes, mixing, filtering for sterilization, and then performing freeze-drying treatment to obtain stem cell extract freeze-dried powder; adding ultrapure water to a final volume of 100 ml; the freeze-drying treatment is that the freeze-drying temperature is-20 to-35 ℃, the vacuum degree is 50 to 200Pa, and the freeze-drying is carried out for 48 hours.
The cell growth medium in this example is DMEM medium containing 5% fetal bovine serum, and the culture medium further contains an antibacterial antibiotic; the antibacterial antibiotic is penicillin and streptomycin, wherein the final concentration of penicillin in the cell growth solution is 200U/ml, the final concentration of streptomycin in the cell growth solution is 250U/ml, and the DMEM culture solution containing 5% fetal calf serum is obtained by adding 5% fetal calf serum to a commercially available basic DMEM culture solution, and adding penicillin with the final concentration of 200U/ml and streptomycin with the final concentration of 250U/ml to obtain the cell growth solution. The phosphate buffer solution is a PBS solution with the pH value of 7.0-7.2; the excipient is any one of mannitol, trehalose or sucrose; the dosage of the excipient accounts for 5-10% of the total weight of the curcumin-induced reinforcement poultry mesenchymal stem cell exosomes.
Reagent instruments are used in this example:
BCA protein detection kit: # 23225; thermo Fisher Scientific, Waltham, MA, USA;
RIPA buffer: 50 mM Tris-HCl, pH7.4, 150 mM NaCl, 1% Triton X-100, 1% Na-deoxyholate, 0.1% SDS, 0.1 mM CaCl2, and 0.01 mM MgCl2
qEV RNA extraction kit: IZON Science LTD, Christchurch, New Zealand;
protease inhibitor cocktail: thermo Fisher Scientific;
full wavelength microplate reader: molecular Devices, San Jose, Calif., USA;
HitachiHT7700 electron microscope: hitachi, Tokyo, Japan;
a spectral luminance meter: NanoDrop ™ 2000c, Thermo Fisher Scientific;
silica gel insert: culture inserts, 2-well plates, ibiTreat; ibidi, Martinsried, Germany.
Transmission electron microscope using procedure
Curcumin-induced enhancement poultry mesenchymal stem cell exosome frozen crystal powder samples are prepared for transmission electron microscopy. Briefly, exosomes were immobilized on copper mesh, fixed with 1% glutaraldehyde in cold PBS for 5 min to stabilize the immune response, washed with sterile distilled water, compared with a uranium oxalate solution at pH7 for 5 min, and then embedded with methylcellulose on ice for 10 min. Excess cellulose was removed and the samples were dried for permanent storage. The exosome samples were imaged using a HitachiHT7700 electron microscope at 80kV voltage.
Detection of contaminating heteroprotein
The pierce tmbca protein assay kit was used for purity testing. A standard curve (range 0-2000. mu.g/mL) was obtained from nine serial dilutions of Bovine Serum Albumin (BSA) and working reagent. All samples and standard spots were repeated 3 times. Dissolving samples (10 μ l each) (100 mg curcumin-induced rescue poultry mesenchymal stem cell exosome freeze-dried powder or freeze-dried powder of control exosome in 500 μ lQH2O) was mixed with 200 μ l of the working reagent and incubated at 65 ℃ for 30 minutes. After cooling to room temperature, each difference in absorbance (minus the average absorbance of the 562nm blank standard replicate) was measured by a full wavelength microplate reader and converted to μ g/ml through standard curve. If the protein concentration exceeds the upper limit of the standard curve, 2000. mu.g/mL, the sample is diluted to a level that can be determined within the standard range and the final concentrate is calibrated to take into account the dilution factor.
Exosome protein concentration detection step curcumin induces the frozen crystal powder of the exosomes of the rescue poultry interstitial stem cells of 100mg and the frozen crystal powder of the control exosomes to be resuspended in RIPA buffer solution and supplemented with protease inhibitor mixture. The BCA protein assay kit was used for purity testing. Nine serial dilutions were made using Bovine Serum Albumin (BSA) and working reagent to generate a standard curve (range 0-250. mu.g/mL). All samples and standard spots were repeated 3 times. Samples (10. mu.l each) were mixed with 200. mu.l of working reagent and incubated at 65 ℃ for 30 minutes. After cooling to room temperature, each difference in absorbance was measured by a full wavelength microplate reader, the average absorbance at 562nm of the blank standard replicate was subtracted, and the difference in absorbance was converted to μ g/ml by the standard curve.
Exosome RNA concentration detection
Curcumin induces the frozen crystal powder of the exosomes of the enhancement poultry mesenchymal stem cells of 100mg and the frozen crystal powder of the exosomes of 100mg are resuspended in the lysis buffer A of the qEVRNA extraction kit. The detailed extraction method follows the user specification. And detecting the RNA concentrations of the extracted exosomes of the curcumin-induced enhancement poultry interstitial stem cell exosome frozen crystal powder and the control exosomes by using a spectrophotometer.
Cell proliferation assay procedure
To determine cell viability, human skin fibroblasts and human hair follicle cells were cultured in their growth media until they reached 80% density. Cells were treated at 5X 103The total volume of individual cells per well was seeded in 96-well plates at a density of 100 μ l. After inoculation, cells were incubated at 37 ℃ and 5% CO2Medium for 24 hours to allow cell attachment. Cells were then washed once with PBS and the medium was replaced with medium containing 0.25% stripped FBS, starved for 24 hours. Supplemented with curcumin-induced rescue-enhancing avian mesenchymal stem cell exosome cryogels at different concentrations and medium containing 0.25% stripped FBS and treated for 72 hours (human dermal fibroblasts) or 96 hours (human hair follicle cells). Curcumin induces the supplement poultry interstitial stem cell exosome frozen crystal powder culture medium mixture to be renewed every other day. After 72 hours or 96 hours of treatment, the medium containing 20% MTS solution was changed to growth medium and incubated for 2 hours. The absorbance at 490nm was measured for each well using a full wavelength microplate reader.
Procedure for wound healing test
To examine the wound healing effect of curcumin-induced enhancement of avian mesenchymal stem cell exosome cryogel powder on the treatment of human dermal fibroblasts, a wound healing experiment was performed using a silica gel insert, and cells were plated in 24-well plates. Specifically, the cells were incubated at 2.5X 105 cells/cm2Is seeded in two compartments of a silica gel insert. The cells were grown for 24 hours, then the medium was changed to starvation medium (no serum) and cultured for another 24 hours. The culture inserts were removed using sterile forceps, creating a 500 μm wide gap. Media supplemented with curcumin-induced rescue avian mesenchymal stem cell exosome cryogels at different concentrations and 0.25% stripped FBS were added and incubated for 24 hours.
In addition to the above embodiments, the present invention may have other embodiments. All technical solutions formed by adopting equivalent substitutions or equivalent transformations fall within the protection scope of the claims of the present invention.

Claims (8)

1. An induced reinforcement preparation process of an avian mesenchymal stem cell exosome is characterized by comprising the following steps:
s1: carrying out primary isolation culture on the poultry mesenchymal stem cells, carrying out subculture, and taking subcultured P3-P30 generation human adipose mesenchymal stem cells;
s2: culturing with cell growth liquid until 75-85% of cells are fused, discarding the culture liquid, washing the cells with phosphate buffer solution for three times, adding curcumin, culturing with serum-free culture liquid for 72 hr, and collecting the serum-free culture liquid;
s3: continuing the curcumin stimulation treatment of the step until the serum-free culture solution is collected, wherein the cells which are not collected in the step S2 are not collected;
s4: collecting serum-free culture solution stimulated by curcumin in the steps S2 and S3, centrifuging, extracting and concentrating the exosome filtrate, and finally preparing the needed curcumin to induce the reinforcement poultry mesenchymal stem cell exosomes after degerming treatment is carried out on the obtained exosome concentrated filtrate;
s5: adding excipient and water into curcumin-induced aid-increasing poultry mesenchymal stem cell exosome, mixing, filtering for sterilization, and freeze-drying to obtain the stem cell extract freeze-dried powder.
2. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein: the cell growth solution is DMEM culture solution containing 5% fetal calf serum, and the culture solution also contains antibacterial antibiotics; the antibacterial antibiotic is penicillin and streptomycin, wherein the final concentration of penicillin in a cell growth solution is 200U/ml, the final concentration of streptomycin in the cell growth solution is 250U/ml, the DMEM culture solution containing 5% fetal calf serum is obtained by adding 5% of fetal calf serum into a commercially available basic DMEM culture solution, and the penicillin with the final concentration of 200U/ml and the streptomycin with the final concentration of 250U/ml are added to obtain the cell growth solution.
3. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein: the phosphate buffer solution is a PBS solution with the pH value of 7.0-7.2.
4. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein: the excipient is any one of mannitol, trehalose or sucrose; the dosage of the excipient accounts for 5-10% of the total weight of the curcumin-induced reinforcement poultry mesenchymal stem cell exosomes.
5. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein: the water in the step S5 is ultrapure water, and ultrapure water is added to a final volume of 100 ml.
6. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein: the freeze-drying treatment is that the freeze-drying temperature is-20 to-35 ℃, the vacuum degree is 50 to 200Pa, and the freeze-drying is carried out for 48 hours.
7. The process for preparing exosomes of avian mesenchymal stem cells according to claim 1, wherein:
the centrifugation operation of the step S4 is to adopt the centrifugation process of 1,000Xg10 minutes and 10,000Xg10 minutes, collect the supernatant after the centrifugation is finished, flow the collected supernatant through the hollow fiber membrane to carry out tangential flow filtration, collect the filtered and concentrated exosome solution and then pass through an exosome extraction system to extract the high-purity exosome solution, and the sterilization treatment adopts a sterile 0.22 mu m filter membrane to carry out filtration sterilization.
8. The application of the poultry mesenchymal stem cell exosome is characterized in that: preparing a wound healing medicament or a cell repairing medicament by using the stem cell extract cryolite powder; preparing a whitening product or a fine chemical product for resisting skin wrinkles.
CN202110794777.XA 2021-07-14 2021-07-14 Preparation process and application of induced enhancement of exosomes of mesenchymal stem cells of birds Active CN113699103B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110794777.XA CN113699103B (en) 2021-07-14 2021-07-14 Preparation process and application of induced enhancement of exosomes of mesenchymal stem cells of birds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110794777.XA CN113699103B (en) 2021-07-14 2021-07-14 Preparation process and application of induced enhancement of exosomes of mesenchymal stem cells of birds

Publications (2)

Publication Number Publication Date
CN113699103A true CN113699103A (en) 2021-11-26
CN113699103B CN113699103B (en) 2023-04-25

Family

ID=78648644

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110794777.XA Active CN113699103B (en) 2021-07-14 2021-07-14 Preparation process and application of induced enhancement of exosomes of mesenchymal stem cells of birds

Country Status (1)

Country Link
CN (1) CN113699103B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117721070A (en) * 2024-02-07 2024-03-19 国典(北京)医药科技有限公司 Method for detecting purity of hiPSC source exosome and special digestive agent thereof
JP7453705B2 (en) 2022-02-14 2024-03-21 陞醫生物科技股▲分▼有限公司 Exosomes and their preparation process and their use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784474A (en) * 2014-01-26 2014-05-14 广州赛莱拉生物科技有限公司 Human fat mesenchymal stem cell extract and lyophilized powder and application thereof
CN108451887A (en) * 2018-03-27 2018-08-28 深圳市兰亭科技股份有限公司 The skin care compositions and methods and application thereof of the body of excretion containing stem cell source
CN109097326A (en) * 2018-08-10 2018-12-28 广东唯泰生物科技有限公司 A kind of method and its application preparing mescenchymal stem cell excretion body

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784474A (en) * 2014-01-26 2014-05-14 广州赛莱拉生物科技有限公司 Human fat mesenchymal stem cell extract and lyophilized powder and application thereof
CN108451887A (en) * 2018-03-27 2018-08-28 深圳市兰亭科技股份有限公司 The skin care compositions and methods and application thereof of the body of excretion containing stem cell source
CN109097326A (en) * 2018-08-10 2018-12-28 广东唯泰生物科技有限公司 A kind of method and its application preparing mescenchymal stem cell excretion body

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘金伟: "人脂肪间充质干细胞外泌体通过上调β-catenin、c-Myc和细胞周期蛋白表达促进表皮干细胞增殖" *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7453705B2 (en) 2022-02-14 2024-03-21 陞醫生物科技股▲分▼有限公司 Exosomes and their preparation process and their use
CN117721070A (en) * 2024-02-07 2024-03-19 国典(北京)医药科技有限公司 Method for detecting purity of hiPSC source exosome and special digestive agent thereof
CN117721070B (en) * 2024-02-07 2024-05-10 国典(北京)医药科技有限公司 Method for detecting purity of hiPSC source exosome and special digestive agent thereof

Also Published As

Publication number Publication date
CN113699103B (en) 2023-04-25

Similar Documents

Publication Publication Date Title
CN109536440A (en) The extracting method of excretion body
JP2019517488A (en) Human platelet lysate-derived extracellular vesicles for use in medicine
CN111249449B (en) Extracellular vesicle-interleukin-10 nano targeted drug and preparation method and application thereof
CN113699103A (en) Induced reinforcement preparation process and application of poultry mesenchymal stem cell exosomes
CN114591905B (en) Method for preparing apoptotic vesicles from human erythrocytes and application of apoptotic vesicles
JP2010538681A (en) Methods for extracting mesenchymal stem cells from human or animal embryos and their secretions
CN114306384B (en) Application of human platelet apoptosis microvesicle
CN108715830A (en) Urinate extracting method and its application of derived stem cell excretion body
CN113321709A (en) Self-assembled polypeptide, slow-release exosome polypeptide hydrogel and preparation method and application thereof
CN116024157A (en) Preparation method of ginger exosomes
CN114874981A (en) Mesenchymal stem cell exosome and application thereof in immune cell culture
CN102747033A (en) Method for culturing mesenchymal stem cells and fibroblast tissue from gingival tissue
CN109200011A (en) A kind of skin care item and preparation method thereof
CN116064387A (en) Preparation and application of epimedium vesicles
CN116496971A (en) Mugwort leaf-derived exosome-like nano vesicle and application and medicament thereof
CN114652703B (en) Application of aerosol inhalation functional extracellular vesicles in improving acute lung injury
RU2710368C2 (en) METHOD OF PRODUCING AND CONCENTRATING microRNA-CONTAINING EXOSOMES OF MULTIPOTENT MESENCHYMAL STROMAL CELLS FOR USE IN COSMETIC AND MEDICINAL AGENTS FOR STIMULATING REGENERATIVE PROCESSES AND SLOWING DOWN AGING PROCESSES
KR102424333B1 (en) Method for mass production of high-purity extracellular vesicles derived from stem cells using peptides
JP6188249B2 (en) Wound healing composition derived from porcine umbilical cord tissue, method for producing the same, and pharmaceutical product for wound healing containing the composition
JP2016079177A (en) Composition which promotes growth of dermal papilla cell, method for manufacturing the same, and medicinal drug containing the composition
TWI828062B (en) Methods for producing exosomes, the exosomes produced and their applications
CN117586955B (en) Preparation and application of EPO-stimulated macrophage-derived exosome
AU2021106118A4 (en) Use of microvesicle derived from umbilical cord mesenchymal stem cell in preparation of formulation for promoting regeneration of post-traumatic skin appendage
KR20200001370A (en) Crushed Stem Cell Extract(Shelled Stem Cell) Manufacturing Method Using Mass Culture Medium Composition Method and Constituent 3-low Extracting Method and A Treating Composition for Anti-Inflammatory and A Treating Composition for Cell Regeneration
KR102563616B1 (en) Soluble extracellular matrix derived from stem cells and preparing method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20231222

Address after: Taipei City, Taiwan, China

Patentee after: Shengyi Biotechnology Co.,Ltd.

Address before: Unit G1-1101-023, Artificial Intelligence Industrial Park, No. 88 Jinjihu Avenue, Suzhou Industrial Park, Suzhou City, Jiangsu Province, 215000

Patentee before: Xie Rusheng

TR01 Transfer of patent right